Pharmascroll, a Market Research and Business Consulting firm, has come up with an extensive range of portfolio with the launch of over 30 reports in multiple indications. These reports have been launched in the Progressive Multiple Sclerosis indications including Secondary Progressive MS and Primary Progressive MS and in the Migraine Indication.

The research reports provide overview of the disease indications in detail, highlight the disease epidemiology in the key geographies, elaborate on the drugs prescribed and expected to be prescribed in the disease indications and cover the detailed market sizing drug wise and country wise in value sales and patient numbers along with forecasts.

“The reports would help the pharma companies understand the disease indications in detail, identify business opportunities for making short term and long term plans, understand the epidemiology and identify the triggers of prescription for the physicians in disease indications and make companies aware of the existing and upcoming competition along with their expected sales revenues and patient numbers in key geographies”, said Bhawna Gupta, one of the Directors of Pharmascroll.

About Pharmascroll:
Pharmascroll is a diligent business consulting and market research firm focused solely towards pharmaceutical markets. The company consults and researches in majorly chronic disease indications prevalent across the globe. The research conducted by Pharmascroll analysts is targeted to provide analytical and logical answers to the key business questions of the pharmaceutical and medical insights teams and to make better informed business decisions with the detailed relevant information available.

For more details about the company visit www.pharmascroll.com